Skip to main content

Table 3 Comparison between genotype SOD in ESRD among clinical data

From: Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients

  Genotype SOD One way ANOVA
Ala/Ala Val/Ala Val/Val
       F P
Hb Conc. 10.21 1.61 10.36 1.82 9.93 2.05 0.524 0.594
Duration of dialysis (months) 10.40 8.25 20.00 25.96 40.74 42.06 5.398 0.006
Ca Conc. 7.65 1.78 8.07 1.12 8.49 0.97 3.150 0.047
Phosphate 4.85 1.43 6.20 2.39 6.04 2.51 1.277 0.283
PTH 449.20 318.01 439.66 380.49 503.33 489.40 0.236 0.791
Creat Conc. 8.07 3.39 8.00 3.52 8.12 2.71 0.016 0.984
Bilirubin 0.67 0.15 0.61 0.22 0.63 0.19 0.397 0.673
Albumin 3.99 0.33 3.85 0.46 3.80 0.43 0.846 0.432
SGPT 19.90 6.51 29.94 22.03 26.71 23.34 0.819 0.444
SGOT 21.70 4.03 33.38 21.26 30.26 22.65 1.164 0.317
FBS 156.70 80.88 106.03 39.87 131.00 75.82 2.672 0.074
  No % No % No % Chi-square test
HBsAg Negative 10 100.00 2 100.00 30 100.00 NA NA
HCV Negative 10 100.00 2 100.00 20 66.70 5.131 0.162
Positive 0 0.00 0 0.00 10 33.30